Sanofi-Aventis Acomplia Faces Good Reception From Physicians And Payers

Acomplia'schances of gaining acceptance as treatment for metabolic syndrome are improved by its effects on a range of the disease's comorbidities, according to Decision Resources analyst Donny Wong